These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2207331)

  • 1. Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia.
    Faisal M; Cumberland W; Champlin R; Fahey JL
    Blood; 1990 Oct; 76(8):1580-5. PubMed ID: 2207331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
    Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
    Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
    Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
    Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer.
    Setti M; Bignardi D; Ballestrero A; Ferrando F; Musselli C; Blanchi S; Basso M; Bosco O; Balleari E; Patrone F; Indiveri F
    Cancer Immunol Immunother; 1999 Sep; 48(6):287-96. PubMed ID: 10473803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effect of granulocyte-macrophage colony-stimulating factor on the generation of natural killer cells in vitro.
    Taguchi K; Shibuya A; Inazawa Y; Abe T
    Blood; 1992 Jun; 79(12):3227-32. PubMed ID: 1375846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of granulocyte-macrophage colony-stimulating factor therapy on the generation of natural killer cells.
    Shibuya A; Taguchi K; Kojima H; Abe T
    Blood; 1991 Dec; 78(12):3241-7. PubMed ID: 1720700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma.
    Ho AD; Haas R; Wulf G; Knauf W; Ehrhardt R; Heilig B; Körbling M; Schulz G; Hunstein W
    Blood; 1990 Jan; 75(1):203-12. PubMed ID: 2104762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of HLA-DR and co-stimulatory molecule expression on natural killer T cells by granulocyte-macrophage colony-stimulating factor.
    Saikh KU; Kissner T; Ulrich RG
    Immunology; 2002 Jul; 106(3):363-72. PubMed ID: 12100724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
    Echaniz P; Arrizabalaga J; Iribarren JA; Cuadrado E
    Cell Immunol; 1993 Aug; 150(1):72-80. PubMed ID: 7688270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficit of circulating CD19
    Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
    Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.
    Orazi A; Cattoretti G; Schiró R; Siena S; Bregni M; Di Nicola M; Gianni AM
    Blood; 1992 May; 79(10):2610-9. PubMed ID: 1586713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia.
    Guinan EC; Sieff CA; Oette DH; Nathan DG
    Blood; 1990 Sep; 76(6):1077-82. PubMed ID: 2205306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.
    Tsegaye A; Wolday D; Otto S; Petros B; Assefa T; Alebachew T; Hailu E; Adugna F; Measho W; Dorigo W; Fontanet AL; van Baarle D; Miedema F
    Clin Immunol; 2003 Dec; 109(3):338-46. PubMed ID: 14697749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human GM-CSF enhances T cell-mediated cytotoxic function after ABMT for hematological malignancies.
    Richard C; Alsar MJ; Calavia J; Bello-Fernandez C; Baro J; Loyola I; Rios R; Cuadrado MA; Gonzalez-Pardo C; Iriondo A
    Bone Marrow Transplant; 1993 Jun; 11(6):473-8. PubMed ID: 8334429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
    Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
    Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells.
    Toor AA; Lund TC; Miller JS
    Exp Hematol; 2001 Apr; 29(4):499-506. PubMed ID: 11301190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant human granulocyte-colony stimulation factor (rhG-CSF) on immune system in pediatric patients with aplastic anemia.
    Hibi S; Yoshihara T; Nakajima F; Misu H; Mabuchi O; Imashuku S
    Pediatr Hematol Oncol; 1994; 11(3):319-23. PubMed ID: 7520260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.